首页> 美国卫生研究院文献>other >Effect of Oxaliplatin Fluorouracil and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

【2h】

Effect of Oxaliplatin Fluorouracil and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

机译：影响奥沙利铂氟尿嘧啶亚叶酸钙和带或不带西妥昔单抗对生存的患者中切除的III期结肠癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ContextLeucovorin, fluorouracil, and oxaliplatin (FOLFOX) is the standard adjuvant therapy for resected stage III colon cancer. Adding cetuximab to FOLFOX benefits patients with metastatic wild-type KRAS but not mutated KRAS colon cancer.

机译：ContextLeucovorin，氟尿嘧啶和oxaliplatin（Folfox）是切除阶段III结肠癌的标准佐剂疗法。将甲磺酰突然伴有转移性野生型KRA患者添加到FELFOX中，但不突变KRAS结肠癌。

著录项

期刊名称 other
作者
Steven R. Alberts; Daniel J. Sargent; Suresh Nair; Michelle R. Mahoney; Margaret Mooney; Stephen N. Thibodeau; Thomas C. Smyrk; Frank A. Sinicrope; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; Anthony F. Shields; James T. Quesenberry; Thomas A. Webb; Gist H. Farr Jr; Barbara A. Pockaj; Axel Grothey; Richard M. Goldberg;
展开▼
作者单位

展开▼
年(卷),期 -1(307),13
年度 -1
页码 1383–1393
总页数 21
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: A randomized trial [J] . AlbertsS.R., SargentD.J., NairS., JAMA: the Journal of the American Medical Association . 2012,第13期

机译：Oxaliplatin，氟尿嘧啶和白草素，或不含甲磺素素对切除阶段III癌症患者生存的影响：随机试验
2. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): An open-label, randomised phase 3 trial [J] . TaiebJ., TaberneroJ., MiniE., The lancet oncology . 2014,第8期

机译：奥沙利铂，氟尿嘧啶和亚叶酸在有或没有西妥昔单抗的切除的III期结肠癌（PETACC-8）患者中：一项开放标签，随机的3期临床试验
3. Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. [J] . Zaanan A, Cuilliere Dartigues P, Guilloux A, Annals of oncology: official journal of the European Society for Medical Oncology . 2010,第4期

机译：p53表达和微卫星不稳定性对5-氟尿嘧啶和亚叶酸钙联合或不联合奥沙利铂治疗的III期结肠癌无病生存的影响。
4. FDG uptake as a biological prognostic factor for recurrence in patients with surgically resected stage Ⅰ non-small cell lung cancer [C] . The First China-Japan-Korea conference of nuclear medicine . 2002

机译：手术切除的Ⅰ期非小细胞肺癌患者FDG摄取是复发的生物学预后因素
5. The Association of Hospital and Patient Characteristics with Treatment Initiation among Veterans with Stage I, II, or III Lung, Colon or Rectal Cancer [D] . Clary, Alecia S. 2019

机译：具有阶段I，II或III肺，结肠或直肠癌的退伍军人治疗发起的医院和患者特征
6. Effect of Adjuvant Capecitabine or Fluorouracil with or without Oxaliplatin on Survival Outcomes in Stage III Colon Cancer and the Effect of Oxaliplatin on Post-Relapse Survival: A Pooled Analysis of Individual Patient Data from Four Randomised Controlled Trials [O] . Hans-Joachim Schmoll, Chris Twelves, Weijing Sun, -1

机译：卡培他滨或氟尿嘧啶辅助药物（含或不含奥沙利铂）对III期结肠癌生存率的影响以及奥沙利铂对复发后生存率的影响：来自四个随机对照试验的单个患者数据的汇总分析
7. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204) [O] . A. Bapsi Chakravarthy, Fengmin Zhao, Neal J. Meropol, 2019

机译：术后Oxaliplatin，5-氟尿嘧啶和白杨蛋白的跨组随机化第三阶段研究术前II或III型直肠癌患者的奥沙利铂，5-氟尿嘧啶，白草素和Bevacizumab接受术前化学校长：ECOG-acrin研究组的试验（E5204 ）

Effect of Oxaliplatin Fluorouracil and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

摘要

著录项

相似文献

相关主题

期刊订阅